Department of Immunology, Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russian Federation.
PLoS One. 2010 May 4;5(5):e10469. doi: 10.1371/journal.pone.0010469.
Infection with Mycobacterium tuberculosis (Mtb) results in different clinical outcomes ranging from asymptomatic containment to rapidly progressing tuberculosis (TB). The mechanisms controlling TB progression in immunologically-competent hosts remain unclear.
METHODOLOGY/PRINCIPAL FINDINGS: To address these mechanisms, we analyzed TB progression in a panel of genetically heterogeneous (A/SnxI/St) F2 mice, originating from TB-highly-susceptible I/St and more resistant A/Sn mice. In F2 mice the rates of TB progression differed. In mice that did not reach terminal stage of infection, TB progression did not correlate with lung Mtb loads. Nor was TB progression correlated with lung expression of factors involved in antibacterial immunity, such as iNOS, IFN-gamma, or IL-12p40. The major characteristics of progressing TB was high lung expression of the inflammation-related factors IL-1beta, IL-6, IL-11 (p<0.0003); CCL3, CCL4, CXCL2 (p<0.002); MMP-8 (p<0.0001). The major predictors of TB progression were high expressions of IL-1beta and IL-11. TNF-alpha had both protective and harmful effects. Factors associated with TB progression were expressed mainly by macrophages (F4-80(+) cells) and granulocytes (Gr-1(hi)/Ly-6G(hi) cells). Macrophages and granulocytes from I/St and A/Sn parental strains exhibited intrinsic differences in the expression of inflammatory factors, suggesting that genetically determined peculiarities of phagocytes transcriptional response could account for the peculiarities of gene expression in the infected lungs. Another characteristic feature of progressing TB was the accumulation in the infected lungs of Gr-1(dim) cells that could contribute to TB progression.
CONCLUSIONS/SIGNIFICANCE: In a population of immunocompetent hosts, the outcome of TB depends on quantitatively- and genetically-controlled differences in the intensity of inflammatory responses, rather than being a direct consequence of mycobacterial colonization. Local accumulation of Gr-1(dim) cells is a newly identified feature of progressing TB. High expression of IL-1beta and IL-11 are potential risk factors for TB progression and possible targets for TB immunomodulation.
结核分枝杆菌(Mtb)感染导致不同的临床结果,从无症状的控制到快速进展的结核病(TB)不等。在免疫功能正常的宿主中控制 TB 进展的机制仍不清楚。
方法/主要发现:为了研究这些机制,我们分析了一组遗传异质性(A/SnxI/St)F2 小鼠的 TB 进展情况,这些小鼠源自易患 TB 的 I/St 和更具抗性的 A/Sn 小鼠。在 F2 小鼠中,TB 的进展速度不同。在未达到感染终末期的小鼠中,TB 的进展与肺部 Mtb 负荷无关。TB 的进展也与参与抗菌免疫的因子,如 iNOS、IFN-γ或 IL-12p40 的肺部表达无关。进展性 TB 的主要特征是炎症相关因子 IL-1β、IL-6、IL-11(p<0.0003);CCL3、CCL4、CXCL2(p<0.002);MMP-8(p<0.0001)的高肺表达。TB 进展的主要预测因子是 IL-1β和 IL-11 的高表达。TNF-α 既有保护作用又有有害作用。与 TB 进展相关的因素主要由巨噬细胞(F4-80+细胞)和粒细胞(Gr-1高/Ly-6G 高细胞)表达。I/St 和 A/Sn 亲本株的巨噬细胞和粒细胞在炎症因子的表达上存在内在差异,这表明吞噬细胞转录反应的遗传决定的特性可以解释感染肺部基因表达的特殊性。进展性 TB 的另一个特征是在感染的肺部积累 Gr-1(低)细胞,这可能有助于 TB 的进展。
结论/意义:在免疫功能正常的宿主群体中,TB 的结果取决于炎症反应强度的定量和遗传控制差异,而不是直接由分枝杆菌定植引起的。Gr-1(低)细胞在感染肺部的积累是进展性 TB 的一个新特征。IL-1β和 IL-11 的高表达是 TB 进展的潜在危险因素,也是 TB 免疫调节的潜在靶点。